Federated Hermes, Inc. 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-07 10:14 am Sale |
2023-08-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
2,341,335 4.110% |
-3,963,147 (-62.86%) |
Filing |
| 2023-02-01 11:57 am Purchase |
2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
6,304,482 11.190% |
1,239,369 (+24.47%) |
Filing |
| 2022-04-11 11:14 am Purchase |
2022-03-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
5,065,113 10.060% |
2,261,778 (+80.68%) |
Filing |
| 2022-02-14 2:53 pm Purchase |
2021-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
2,803,335 5.580% |
1,027,631 (+57.87%) |
Filing |
| 2021-12-10 1:18 pm Sale |
2021-11-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
1,775,704 3.530% |
-841,896 (-32.16%) |
Filing |
| 2021-02-12 3:20 pm Purchase |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
2,617,600 5.920% |
2,617,600 (New Position) |
Filing |